[EN] THERAPEUTIC COMPOSITIONS CONTAINING A HEXAHYDRO-5-PYRIMIDINAMINE COMPOUND AND A MORPHOLINE-ETHER COMPOUND<br/>[FR] COMPOSITIONS THERAPEUTIQUES CONTENANT UN COMPOSE HEXAHYDRO-5-PYRIMIDINAMINE ET UN COMPOSE MORPHOLINE-ETHER
申请人:WARNER-LAMBERT COMPANY
公开号:WO1997028805A1
公开(公告)日:1997-08-14
(EN) A therapeutic composition containing an antimicrobial hexahydro-5-pyrimidinamine compound and an anesthetic morpholine-ether compound in a pharmaceutically acceptable carrier is disclosed. The composition may be an oral topical composition or a non-oral topical composition. The preferred hexahydro-5-pyrimidinamine composition is hexetidine. The preferred morpholine-ether composition is pramoxine(4-[3-(4-butoryphenoxy)prozsyl]morpholine).(FR) L'invention concerne une composition thérapeutique contenant un composé antimicrobien hexahydro-5-pyrimidinamine et un composé anesthésique morpholine-éther dans un excipient pharmaceutiquement acceptable. Cette composition peut être une composition à action locale et à administration orale ou une composition à action locale à administration non orale. La composition préférée hexahydro-5-pyrimidinamine est hexétidine. La composition préférée morphoholine-éther est pramoxine(4-[3-(4-butoryphénoxy)prozsyl]morpholine).
[EN] COLD TEMPERATURE STABLE BIOCIDAL COMPOSITION<br/>[FR] COMPOSITION BIOCIDE STABLE À BASSE TEMPÉRATURE
申请人:DOW GLOBAL TECHNOLOGIES INC
公开号:WO2010117650A2
公开(公告)日:2010-10-14
Provided is a synergistic biocidal composition comprising a biocidal N-(2-nitroalkyl) morpholine compound of formula (I), where R, x, and y are as defined herein, together with an aromatic alcohol. The composition is cold temperature stable and is therefore useful for the control of microorganisms in a variety of matrices, including liquid fuels.
REACTIONS OF MORPHOLINEMETHANOL WITH COMPOUNDS CONTAINING ACTIVE HYDROGEN ATOMS